GURUFOCUS.COM » STOCK LIST » USA » NYSE » Teva Pharmaceutical Industries Ltd (NYSE:TEVA) » Definitions » Dividend Yield %
Switch to:

Teva Pharmaceutical Industries (NYSE:TEVA) Dividend Yield %

: 0.00% (As of Today)
View and export this data going back to 1990. Start your Free Trial

As of today (2023-01-29), the Trailing Annual Dividend Yield of Teva Pharmaceutical Industries is 0.00%.

The historical rank and industry rank for Teva Pharmaceutical Industries's Dividend Yield % or its related term are showing as below:

During the past 13 years, the highest Dividend Yield of Teva Pharmaceutical Industries was 9.19%. The lowest was 0.00%. And the median was 2.44%.

Teva Pharmaceutical Industries's Dividend Payout Ratio for the three months ended in Sep. 2022 was 0.00.

During the past 13 years, the highest Dividend Payout Ratio of Teva Pharmaceutical Industries was 19.41. The lowest was 0.00. And the median was 0.74.

As of today (2023-01-29), the Forward Dividend Yield % of Teva Pharmaceutical Industries is 0.00%.

Teva Pharmaceutical Industries's Dividends per Share for the three months ended in Sep. 2022 was $0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Teva Pharmaceutical Industries was 73.90% per year. The lowest was -100.00% per year. And the median was 20.75% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Teva Pharmaceutical Industries Dividend Yield % Historical Data

The historical data trend for Teva Pharmaceutical Industries's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Dividend Yield %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.49 0.55 - - -

Teva Pharmaceutical Industries Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Dividend Yield % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Teva Pharmaceutical Industries Dividend Yield % Distribution

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Dividend Yield % falls in comparison to its industry or sector. The grey bar indicates the Dividend Yield %'s extreme value range as defined by GuruFocus.



Teva Pharmaceutical Industries Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Teva Pharmaceutical Industries  (NYSE:TEVA) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Teva Pharmaceutical Industries Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Teva Pharmaceutical Industries (NYSE:TEVA) Business Description

Teva Pharmaceutical Industries logo
Address
124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Based in Israel, Teva is one of the world's largest generic drug manufacturers, with over 3,500 products marketed in over 60 countries. While a majority of its revenue is attributed to prescription generic drugs, Teva develops and markets its own branded specialty and biopharmaceutical products, primarily in the U.S. and in Europe. The company's branded portfolio generates one fifth of total revenue and consists of patented therapies targeting central nervous system conditions (Austedo, Ajovy, Copaxone), oncology (Bendeka/Treanda), and respiratory conditions (ProAir, Qvar). While global competition has facilitated the commodification of small-molecule generic drugs, Teva's portfolio rationalization has resulted in less overall price erosion versus peers.
Executives
Weiss Amir officer: Chief Accounting Officer C/O TEVA 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Zaks Tal Zvi director C/O ADAPTIMMUNE THERAPEUTICS PLC 60 JUBILEE AVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Inbar Galia officer: See "Remarks" C/O TEVA 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Shani Eli officer: EVP,Global Marketing&Portfolio C/O TEVA 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Weil Andrew officer: Chief Accounting Officer C/O TEVA 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Hussain Abbas director C/O TEVA 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Vergis Janet S. director C/O DENTSPLY SIRONA INC. 13320 BALLANTYNE CORPORATE PLACE CHARLOTTE NC 28277
Kalif Eliyahu Sharon officer: EVP, Chief Financial Officer C/O TEVA, 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Drape Eric officer: Executive VP Global Operations C/O TEVA, 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Satchi-fainaro Ronit director 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Sabag Mark officer: EVP, Global Human Resources 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Codner Iris Beck officer: EVP Global Brand&Communication 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
De Notaristefani Carlo officer: Executive VP Global Operations 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Mcclellan Michael James officer: EVP, Chief Financial Officer 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Suesskind Dan S director C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 49131

Teva Pharmaceutical Industries (NYSE:TEVA) Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
premium membership